| ASSET | QUARTER | % RETURN |
|---|---|---|
Futu (FUTU) | Q2 2022 | 44.51% |
Li Auto (LI) | Q2 2022 | 40.07% |
PDD (PDD) | Q2 2022 | 38.81% |
United Therapeutics (UTHR) | Q2 2022 | 30.48% |
Ke Holdings (BEKE) | Q2 2022 | 27.67% |
argenx NV ADR (ARGX) | Q2 2022 | 20.01% |
PBF Energy (PBF) | Q2 2022 | 19.67% |
AT&T (T) | Q2 2022 | 18.68% |
Monster Beverage (MNST) | Q2 2022 | 15.47% |
Cenovus Energy (CVE) | Q2 2022 | 14.45% |
HF Sinclair (DINO) | Q2 2022 | 14.03% |
Eli Lilly and (LLY) | Q2 2022 | 13.69% |
Coca-Cola Consolidated (COKE) | Q2 2022 | 12.39% |
Texas Pacific Land (TPL) | Q2 2022 | 12.06% |
General Mills (GIS) | Q2 2022 | 11.91% |
Merck (MRK) | Q2 2022 | 11.83% |
Penske Automotive (PAG) | Q2 2022 | 11.7% |
Yum China (YUMC) | Q2 2022 | 11.29% |
Trip Group Ltd ADR (TCOM) | Q2 2022 | 11.13% |
Symbotic (SYM) | Q2 2022 | 10.58% |
RB Global (RBA) | Q2 2022 | 10.53% |
Kimberly-Clark (KMB) | Q2 2022 | 10.46% |
Dollar General (DG) | Q2 2022 | 10.29% |
International Business Machines (IBM) | Q2 2022 | 10.21% |
Halozyme Therapeutics (HALO) | Q2 2022 | 10% |
Large-cap stocks are treated as having a market cap of $10B+.
